News
-
Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver
October 25, 2023 -
Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting
October 24, 2023 -
Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan
October 23, 2023 -
Aclarion Provides Updated Investor Presentation and Corporate Update
October 2, 2023 -
Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report
August 25, 2023 -
Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI
June 14, 2023 -
Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting
June 8, 2023 -
Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
May 30, 2023 -
Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD
May 23, 2023 -
Aclarion, Inc. Announces Delayed 10-Q Filing
May 23, 2023